In the BioHarmony Drug Report Database
Nuzyra (omadacycline) is a small molecule pharmaceutical. Omadacycline was first approved as Nuzyra on 2018-10-02. It is used to treat bacterial infections, bacterial pneumonia, and bacterial skin diseases in the USA. Nuzyra’s patents are valid until 2037-10-31 (FDA).
Image (chem structure or protein)